Heritage Cannabis’ (CANN.C) subsidiary, CannaCure, has been granted an amended sales license by Heath Canada, effective April 12, 2021. This license will permit Heritage to
Heritage Cannabis (CANN.C) announced they have expanded their relationship with Merida Capital Holdings in order to aid Heritage’s expansion into the US. Heritage hopes to
Heritage Cannabis Holdings (CANN.C) announced they have received their first order for the RAD and Premium 5 products from New Brunswick. RAD is one of
Heritage Cannabis (CANN.C) has announced the expansion of its U.S. supply and distribution agreement with Geocann. “Obtaining the distribution rights for select VESIsorb™ products in
Heritage Cannabis Holdings (CANN.C) has announced they have closed their overnight marketed public offering after raising gross proceeds of $13,846,000. The offering involved selling 98,900,000
Heritage Cannabis (CANN.C) has been granted an export license by Health Canada. The license will permit the Company to export cannabis products to Brazil marking
Heritage is focused on becoming a vertically integrated cannabis provider that currently has two Health Canada approved licenced producers, through its subsidiaries Voyage Cannabis and
Heritage Cannabis Holdings (CANN.C) is now selling their Purefarma and Pura Vida products on their EndoDNA site myDNA.live as of today, according to a press
Heritage Cannabis Holdings (CANN.C) closed its acquisition of Canadian-based recreational and medical cannabis company, Premium 5, today, according to a press release. Premium 5 products
Heritage Cannabis Holdings (CANN.C) subsidiary, CannaCure, got in on a binding letter of intent for a three year extraction and finished product supply deal for
CANN focuses on extraction and the creation of derivative products for recreational and medical consumers.
Heritage Cannabis Holdings (CANN.C) signed into a supply agreement with IntelGenx (IGX.V) to manufacture and supply filmstrip products containing 10 mg of CBD for the
No cannabis companies splits investors squarely down the middle like Heritage Cannabis (CANN.C). Despite ongoing good news and deals with larger players, a sizable section
Heritage Cannabis Holdings (CANN.C) got their first order from the Alberta Gaming, Liquor and Cannabis Commission (AGLC) to start selling products in the province, according
Heritage Cannabis Holdings (CANN.C) announced the execution of a binding letter of intent with pharmaceutical film developer, IntelGenx (IGX.V), to supply CBD filmstrips for the
Heritage Cannabis Holdings (CANN.C) signature tincture brands, Pura Vida and Purefarma, will be on shelves in British Columbia through the province’s Liquor Distribution Branch (LDB)
Unpopular opinion time. Aside from the inconvenience of actually getting sick, the fallout from the COVID-19 pandemic has been vastly worse than the disease itself.
CannaCure’s goal is “to transform the global marijuana landscape through innovative growth strategies and strategic partnerships with manufacturers of cannabis products.”
A widening distribution net with award winning products and it shouldn’t come as much of a surprise that Heritage Cannabis (CANN.C) has had an excellent
Sharples believes that Purefarma, Pura Vida, new contract manufacturing agreements, expansion of Canadian territories, the edibles product launch and the acquisition of Opticann expanding CANN’s U.S. presence will accelerate revenue going forward.
Heritage is positioning itself to radically expand its sales territory.
Sharples’ plan is to leverage Opticann’s international relationships to build “an international medical product sales footprint”.
Gross revenue was $1.4-million in the second quarter of 2020, compared with nil in the three-month period ended April 30, 2019.
“In a sector rife with terrible CEOs that have wasted company treasury and goodwill…none come close to Bierman in terms of self enrichment, entitlement, and outward facing douchery,” wrote Chris Parry on January 31, 2020.
